Menu

Back to Medication Guide

Palbociclib

Generic Name: Palbociclib

Brand Names: Ibrance

Palbociclib is a CDK4/6 inhibitor used with hormone therapy for advanced HR+/HER2- breast cancer.

OncologyCDK4/6 Inhibitor

What It's Used For

Palbociclib is prescribed for:

  • HR-positive, HER2-negative advanced breast cancer
  • With aromatase inhibitor (initial therapy)
  • With fulvestrant (after progression)
  • Oncology targeted therapy

First CDK4/6 inhibitor approved for breast cancer.

Side Effects

Common side effects:

  • Neutropenia (very common)
  • Fatigue
  • Nausea
  • Alopecia
  • Diarrhea

Serious side effects:

  • Severe neutropenia
  • Pulmonary embolism
  • Interstitial lung disease

Additional Information

What is Palbociclib?

Palbociclib is a CDK4/6 inhibitor that blocks cell cycle progression in cancer cells.

Neutropenia Management

Neutropenia is expected - requires regular blood count monitoring and dose adjustments.

3 Weeks On, 1 Week Off

Given in 21-day cycles with 1 week off to allow blood counts to recover.

Learn more at MedlinePlus.

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.

Loading questions...

Ask Dr. Zimmer

Have questions about Palbociclib? Get expert answers from Dr. Zimmer.

Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.

Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.